A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.
about
Interventions to improve the appropriate use of polypharmacy for older peopleInterventions to improve the appropriate use of polypharmacy for older peopleStatins in the treatment of chronic heart failure: a systematic reviewRole of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee RecommendationsCCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials.Statins: a perspective for left ventricular hypertrophy treatment.Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization.The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA).Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia--Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.Primary and secondary prevention of heart failure with statins.Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease.The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk.Emerging drugs for acute and chronic heart failure: current and future developments.Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology.Lipid-lowering therapy and outcomes in heart failure.Atorvastatin and statins in the treatment of heart failure.The cholesterol paradox in heart failure.Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptideReducing morbidity and mortality in high risk patients with statins.Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial.Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.Peripheral arterial disease and chronic heart failure: a dangerous mix.Potential role of statin therapy in heart failure, atrial fibrillation and aortic stenosis.Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction.Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease.Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins.Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF.Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy.Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure.Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.Clinical trials update from the American College of Cardiology: Darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND.
P2860
Q24193171-4D25D3A7-65B4-451B-A9B8-DE11AD963755Q24197711-79F1E45B-1A79-476A-AB9C-C1DAE6FD3B0AQ28200294-3005C558-4C84-4D36-8803-E3B0BE7E42D7Q29994487-58D865C3-3FCC-4A15-A4ED-4779A25C3DFAQ34619812-25745875-E9B8-4DEE-A822-627A9252D5FFQ34662787-D48F8E38-E036-4A26-B7D8-287E2C293EE0Q34887388-322C1734-63DA-4964-A536-8DCC0A313DF7Q35531512-B0386F00-C1F1-4978-807E-1DC8C1C334E1Q35605494-4AD3973F-B75D-42C8-B014-98D36E018940Q36357779-979A91A4-06D7-45EE-ACAB-CE0ADDDB4D83Q36520623-36055430-0B0C-47DF-BE1A-52DFEAADC3F7Q36686069-9E9FEB23-7BF5-4F0E-BF20-B95AFB737D2AQ36752063-904E1DB4-9F89-49F0-9543-F6A6D551BA9EQ36752067-94471884-BDF6-4329-87FA-E57C092E491BQ36758585-B6BE686D-7F6B-4DDF-8410-2B3B9A300853Q36811824-7B25BC87-C8DA-4144-9F91-056C973F36E0Q36818242-2D168031-1598-4044-A58B-43BB74BD264FQ37000767-81511C78-6F9F-4B66-9942-55260F4290C7Q37018475-30B21CD6-CBAE-4D9E-B96C-74000BC9B895Q37027838-B82209A1-5E9B-42BF-850D-9D7CA53861DEQ37102996-AEC468FA-A4B0-4777-95F1-E53D1F001C17Q37230464-56E6087B-63AE-43AF-9C50-8D6868F151BEQ37367669-F5D05F76-F1E9-4488-B5CE-03200A666AC5Q37484543-5472ECE9-796D-4D97-B4F5-D98C045039EBQ37891878-EFDD2A24-E7A7-43EB-9DE3-BCDE69CACD49Q38020790-E914022B-AFD7-4616-9625-44DC0C2EF53FQ40274630-2012717A-BEEE-4916-A6B6-FACDB9F9F325Q41255054-EB2961A6-EA2F-4B53-A3E9-C260847C39D1Q43054647-FB19C7DA-1D95-47B3-999A-ABFB33A9F86DQ43188342-F3CB3938-F383-4C41-9CE4-A6DF15E0CAC1Q46160875-00A1D70B-F8F5-4BC1-B368-E2CED4319734Q46247542-62C226CA-B9CD-416C-9103-FF37FF418910Q46819343-114E9175-3C0D-436C-B1C2-5C33736C62C0Q46985775-1FE861B0-FD0A-40F2-935D-1BFEC026B2BBQ48458509-D4C65A7E-908B-4C7F-8413-03269A69C952Q50782057-DC1E1C34-0495-4F8E-BF0B-597FD207F356
P2860
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A statin in the treatment of h ...... and baseline characteristics.
@en
A statin in the treatment of h ...... ational study in heart failure
@nl
type
label
A statin in the treatment of h ...... and baseline characteristics.
@en
A statin in the treatment of h ...... ational study in heart failure
@nl
prefLabel
A statin in the treatment of h ...... and baseline characteristics.
@en
A statin in the treatment of h ...... ational study in heart failure
@nl
P2093
P2860
P1476
A statin in the treatment of h ...... and baseline characteristics.
@en
P2093
Ake Hjalmarson
CORONA Study Group
Christina Eskilson
Finn Waagstein
Hans Wedel
John Wikstrand
Malin Blideskog
Peter Dunselman
Peter Wessman
P2860
P304
P356
10.1016/J.EJHEART.2005.09.005
P577
2005-10-01T00:00:00Z